Diiodo(p-cymene)ruthenium(II) dimer, 97%, 10g

N-(6-Hydrazinyl-6-oxohexyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 97%, 250mg

Pipetta ad inserimento, 280 ml, 1100 mm, 1 pezzo

(R)-(+)-1-(4-Methoxyphenyl)ethylamine hydrochloride, 95.0%, 250mg

4-Nitro-3-(trifluoromethyl)benzonitrile, 95.0%, 25g

3-((Benzyloxy)methyl)-2-(4-methoxybenzyl)-3,4-dihydro-2H-1,2-thiazine 1,1-dioxide, 98%, 100mg

(S)-4-(2,4-Dimethoxybenzyl)-3-methylpiperazin-2-one hydrochloride, 96%, 1g

(S)-2-(4-Aminobutanamido)-3-(1-methyl-1H-imidazol-5-yl)propanoic acid, 95.0%, 5g

3-Phenylpropanoic acid, 98.0%, 500g

5-Amino-3-(2-furyl)pyrazole, 97.0%, 50mg

2-(4-Bromopyridin-2-yl)acetonitrile, 95.0%, 5g

4,4'-Bis(9H-carbazol-9-yl)-2,2'-dimethylbiphenyl>98.0%(HPLC)(N)200mg